In Brief: Senate Medical Technology Caucus
This article was originally published in The Gray Sheet
Senate Medical Technology Caucus: Sen. Rod Grams (R-Minn.) announces formation of the Senate Medical Technology Caucus May 12 at the Medical Device Manufacturers Association's annual meeting in Washington, D.C. Similar to its House counterpart, the caucus will be "an informal, non-dues paying organization" that will focus on problems "facing the medical technology sector through informational briefings" for congressional members and staff, Grams says. The Minnesota Republican currently is soliciting Senate colleagues to join the caucus and is looking for a Democratic member to serve as co-chair. An inaugural meeting tentatively is planned for early summer, with a possible focus on FDA regulatory reform...
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.